Antacids: all 1,673 studies that test it
Page 15 of 17. Open to participants first (138), then studies with results posted, then the rest; newest registration first within each.
- Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in ErbilCompletedNCT00892229Phase 2
- The Comparison of Efficacy for Cervical Ripening in Labor Induction Between Titrated and Conventional Oral MisoprostolCompletedNCT00886860Phase 4
- Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer RebleedingWithdrawnNCT00881413Phase 4
- Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)CompletedNCT00870272Not applicable
- Techniques to Improve Efficacy of Second Trimester Medical TerminationCompletedNCT00864799Not applicable
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal RefluxCompletedNCT00864396Phase 1
- Prevention of Esophageal Variceal RebleedingStatus unknownNCT00863837Phase 4
- The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal InjuriesStatus unknownNCT00862628Not applicable
- Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal BleedingStatus unknownNCT00861640Phase 4
- A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)CompletedNCT00855361Phase 1
- Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump InhibitorStatus unknownNCT00854776Not applicable
- Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori InfectionCompletedNCT00854451Phase 4
- A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNCT00849329Phase 1
- Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal ResectionCompletedNCT00844675Phase 4
- Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/ErosionCompletedNCT00843063Phase 4
- Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori EradicationCompletedNCT00841854Phase 4
- Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer ProphylaxisTerminatedNCT00839488Phase 4
- Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting ConditionsCompletedNCT00835393Phase 1
- Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)CompletedNCT00817245Phase 1/2
- Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The BodyTerminatedNCT00800280Phase 1
- Misoprostol in Termination of First Trimester Missed AbortionCompletedNCT00797693Not applicable
- Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCPCompletedNCT00786695Not applicable
- Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded TrialCompletedNCT00784186Not applicable
- Effect of Eradication of Helicobacter Pylori on the Dyspeptic SymptomsCompletedNCT00772837Not applicable
- Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn ECompletedNCT00761501Phase 1
- A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, InclusiveCompletedNCT00747695Phase 1
- A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, InclusiveCompletedNCT00747526Phase 1
- Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and InfantsCompletedNCT00744419Phase 1
- Intravenous Proton Pump Inhibitor for Peptic Ulcer BleedingCompletedNCT00731601Phase 4
- The Effect of Vitamin D and Calcium on Bone in Pediatric HIVCompletedNCT00724178Phase 2/3
- Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsCompletedNCT00723502Phase 2
- Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus ControlWithdrawnNCT00713947Phase 4
- High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic TreatmentStatus unknownNCT00709046Not applicable
- A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated PneumoniaCompletedNCT00702871Phase 4
- Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime HeartburnCompletedNCT00701259Phase 3
- Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart FailureWithdrawnNCT00699361Phase 3
- Efficacy and Safety Study of Titrated Oral Misoprostol Solution for Labor AugmentationStatus unknownNCT00695331Phase 4
- Study Evaluating the Bioavailability of Naproxen 375 mg in Two FormulationsCompletedNCT00692055Phase 1
- Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free CombinationCompletedNCT00688428Phase 1
- Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)CompletedNCT00687245Phase 1
- Calcium and Lipid MetabolismCompletedNCT00686192Not applicable
- Drug Interaction Study Between AZD3355 and NexiumCompletedNCT00684190Phase 1
- Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart DiseaseCompletedNCT00683111Phase 4
- A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 GenotypesCompletedNCT00681005Not applicable
- Study Evaluating the Effect of Food on the Bioavailability of PN400 ComponentsCompletedNCT00676442Phase 1
- Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese MalesCompletedNCT00676117Phase 1
- Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.CompletedNCT00674245Phase 2/3
- Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical TreatmentCompletedNCT00674232Not applicable
- Misoprostol for the Treatment of Incomplete AbortionCompletedNCT00670761Not applicable
- Study Evaluating the Bioavailability of Naproxen 500 mg in Three FormulationsCompletedNCT00665743Phase 1
- Lansoprazole Versus Mosapride for Functional DyspepsiaCompletedNCT00663897Phase 4
- Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mgCompletedNCT00649493Phase 1
- Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been HealedCompletedNCT00644735Phase 4
- A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive EsophagitisCompletedNCT00641602Phase 4
- Quality of Life Validation in LaryngitisCompletedNCT00641264Phase 4
- Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced GastropathyCompletedNCT00641004Phase 4
- Barrett's Esophagus - 315 - 3 Way Cross OverCompletedNCT00637988Phase 4
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)CompletedNCT00637845Phase 4
- Barrett's Esophagus - 315 - 3 Way Cross-OverCompletedNCT00637559Phase 4
- Open, Randomized, Two Way Crossover 40mg, Orally and IntravenouslyCompletedNCT00635414Phase 4
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is ContinuedCompletedNCT00633672Phase 3
- A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US OnlyCompletedNCT00633412Phase 3
- Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care UnitCompletedNCT00633035Phase 4
- Ulcer Prevention IICompletedNCT00629928Phase 3
- An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00629564Phase 4
- Prevention of Gastric UlcersCompletedNCT00629512Phase 3
- Adult Asthmatics and Acid RefluxCompletedNCT00628953Phase 2
- Chronic Posterior Laryngitis With Suspected Laryngopharyngeal RefluxCompletedNCT00628667Phase 4
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)CompletedNCT00628342Phase 4
- A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00626535Phase 3
- Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and ivCompletedNCT00626262Phase 4
- Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00625495Phase 4
- A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCompletedNCT00625274Phase 4
- Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)CompletedNCT00608712Phase 4
- vMII for Measurement of Oesophageal Bolus Transport and RefluxTerminatedNCT00604942Not applicable
- Labour Induction With Misoprostol, Dinoprostone and Bard CatheterCompletedNCT00602095Phase 3
- Placebo-Controlled Crossover Study for the Investigation of the Effect of Pantoprazole on Cardiac ContractilityCompletedNCT00600041Phase 1
- PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400CompletedNCT00599404Phase 1
- OSTPRE-Fracture Prevention StudyCompletedNCT00592917Phase 4
- Gastric pH in Critically Ill PatientsCompletedNCT00590928Phase 4
- PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal ToxicityCompletedNCT00576706Phase 3
- Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected PatientsCompletedNCT00574925Phase 4
- Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding UlcersCompletedNCT00573924Not applicable
- Hysteroscopy After Pretreatment With Misoprostol and Estradiol TrialCompletedNCT00572819Phase 3
- Effect of Acid Suppression With Esomeprazole on Vocal Cord GranulomasWithdrawnNCT00567658Phase 3
- Histamine H2 Antagonism as Adjuvant Therapy in Treatment Resistant SchizophreniaCompletedNCT00565175Phase 4
- In Vivo Quantification of Dental Demineralisation Using OCT With and Without EsomeprazoleCompletedNCT00564330Phase 1/2
- Regulation of Bone Formation in Renal OsteodystrophyCompletedNCT00560300Phase 2
- A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)CompletedNCT00559182Phase 1
- Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.CompletedNCT00553449Phase 3
- Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.CompletedNCT00551473Phase 1
- The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERDStatus unknownNCT00539786Not applicable
- Optimised Recovery With Accelerated Nutrition and GI EnhancementCompletedNCT00538954Not applicable
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted DosingTerminatedNCT00537732Phase 4
- Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at TermCompletedNCT00529295Phase 3
- PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound PhenomenaStatus unknownNCT00526006Phase 4
- Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori InfectionCompletedNCT00520949Not applicable
- Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic UlcersCompletedNCT00519519Phase 3
- A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled StudyStatus unknownNCT00517270Not applicable
- Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese PatientsCompletedNCT00517114Not applicable